Leonteq Securities AG’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1
Closed -$5 1323
2025
Q1
$5 Hold
1
﹤0.01% 1226
2024
Q4
$3 Hold
1
﹤0.01% 1253
2024
Q3
$5 Hold
1
﹤0.01% 1194
2024
Q2
$4 Hold
1
﹤0.01% 1192
2024
Q1
$5 Hold
1
﹤0.01% 1195
2023
Q4
$4 Hold
1
﹤0.01% 1186
2023
Q3
$4 Hold
1
﹤0.01% 1189
2023
Q2
$10 Hold
1
﹤0.01% 1221
2023
Q1
$10 Hold
1
﹤0.01% 1197
2022
Q4
$9 Hold
1
﹤0.01% 1279
2022
Q3
$15 Hold
1
﹤0.01% 1264
2022
Q2
$13 Hold
1
﹤0.01% 1267
2022
Q1
$17 Hold
1
﹤0.01% 1233
2021
Q4
$26 Buy
+1
New +$31 ﹤0.01% 1249

Other funds holding TSVT

Leonteq Securities AG's TSVT Position: Q2 2025 in Review

Leonteq Securities AG sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 1 share — an estimated $5 sold.

Leonteq Securities AG first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $26 in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Leonteq Securities AG reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Leonteq Securities AG sold 1 2seventy bio share in Q2 2025, an estimated $5.
  • Leonteq Securities AG first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Leonteq Securities AG's 2seventy bio position peaked at $26 in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Leonteq Securities AG's 13F filing for Q2 2025, filed 17 Feb 2026.